SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-008282
Filing Date
2023-03-16
Accepted
2023-03-16 06:36:44
Documents
15
Period of Report
2023-03-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nuvl-20230316.htm   iXBRL 8-K 60256
2 EX-99.1 nuvl-ex99_1.htm EX-99 210373
3 GRAPHIC img8926856_0.jpg GRAPHIC 8464
4 GRAPHIC img8926856_1.jpg GRAPHIC 8464
  Complete submission text file 0000950170-23-008282.txt   434511

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nuvl-20230316_pre.xml EX-101.PRE 11560
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nuvl-20230316.xsd EX-101.SCH 2474
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nuvl-20230316_lab.xml EX-101.LAB 18489
9 EXTRACTED XBRL INSTANCE DOCUMENT nuvl-20230316_htm.xml XML 4883
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40671 | Film No.: 23737061
SIC: 2834 Pharmaceutical Preparations